IMPACT : Publications

2026

FGFR3-driven gene regulatory network analysis reveals a protumoral role for p63 in luminal bladder tumors

Moreno-Vega A, Zambrano M, Estrada-Virrueta L, Meng X, Puig J, Neyret-Kahn H, Shi M, Dufour F, Gilbert G, Li K, Groeneveld C, Fontugne J, Pérez-Escavy M, Dhifli W, Hua C, Cabel L, Krucker C, Tanguy L, Lindskrog SV, Beraud C, Langle YV, Ye T, Tahi F, Davidson I, Paramio JM, Dyrskjøt L, Allory Y, Lluel P, Eiján AM, Elati M, Radvanyi F, Lodillinsky C, Bernard-Pierrot I

J Clin Invest. e193280, 2026.

Consulter sur JCI

Molecular Profiling of Urothelial Bladder Cancer: Bridging Tumor Biology and Clinical Decision-making

Thibault C, Blons H, Allory Y, Harba A, Roumiguié M, Seisen T, Marcq G, Bajeot AS, Leon P, Masson-Lecomte A, Pradère B, Xylinas E, Prost D, Gabriel PE, Laurent-Puig P, Rouprêt M, Audenet F; Cancer Committee of The French Association of Urology (CC-AFU)

Eur Urol Oncol. S2588-9311(26)00182-3, 2026.

Consulter sur PubMed

Prognostic Factors for Overall Survival in the VESPER Trial: Basal Molecular Subtype Is a Relevant Key Factor

Pfister C, Harter V, Fontugne J, Allory Y, Culine S; VESPER Trial Investigators

Eur Urol Oncol. S2588-9311(26)00004-0, 2026.

Consulter sur PubMed

Tobacco's dual genomic footprints in bladder cancer revealed by multi-omics analysis: An SBS4-like LumU-enriched signature and smoking-driven HRD-related genomic instability

Meng XY, Shi MJ, Li S, Liu M, Fontugne J, Song J, Radvanyi F, Wang FB, Bernard-Pierrot I, Wang XH

Genes and Diseases, 2026.

Consulter sur ScienceDirect